maricann group
Cannabis

Ontario-based medical cannabis company Maricann Group Inc. (CSE:MARI) announced the results of its first-quarter of fiscal 2018 on Wednesday.

The company saw a decline in revenue for the quarter, which only reached $600,591 …

Read

Belgravia Capital
Cannabis

Toronto-based Belgravia Capital International (CSE:BLGVF) announced on Wednesday that it had completed its acquisition of the Canadian company R&D Pharma Corp.

Belgravia Capital, who “[develops] new companies with a focus on the legal …

Read